Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion

NCT01997190 is registered in ClinicalTrials.gov with Candel Therapeutics, Inc. as lead sponsor.

NCT NCT01997190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01997190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion
Lead sponsor
Candel Therapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2013
Completion date
February 28, 2018
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lung cancer, malignant pleural effusion, mesothelioma, ovarian cancer